
501 - 1000 employees
🏥 Healthcare
💼 Consulting
📦 Logistics
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
Healthcare • Consulting • Logistics
BioCryst Pharmaceuticals, Inc. is a global biotechnology company focused on the discovery, development, and commercialization of novel oral small-molecule and protein therapeutics for rare diseases, notably hereditary angioedema (HAE). Founded in 1986, BioCryst uses structure-guided drug design, medicinal chemistry, and advanced technologies to develop first-in-class or best-in-class medicines, and works closely with patients, advocacy groups, and global partners to bring treatments to market.
Selected: 🆕 Date Added.
🔥 8 hours ago
Clinical development director leading global trials, regulatory documents, and multidisciplinary teams. BioCryst develops oral and injectable therapeutics for hereditary angioedema and rare diseases.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 10%
🕒 4 days ago
Senior Payroll Manager leading Workday-based U.S. and international payroll for BioCryst, a rare-disease therapeutics company. Modernizing operations through automation, AI, controls, and process redesign.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟠 Senior
🧾 Payroll
👻 Ghost score 10%
🕒 4 days ago
BioCryst VP leading global clinical development for rare-disease therapeutics. Directing clinical programs, teams, vendors, budgets, and patient-focused trial strategy.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 10%
🕒 5 days ago
TMF Manager overseeing eTMF systems, documentation, audits, and inspection readiness for BioCryst’s rare-disease therapeutics. Managing Veeva Vault Clinical, CTMS processes, CRO oversight, and TMF quality.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Manager
👻 Ghost score 10%
🕒 August 25
Rare Disease Specialist marketing BioCryst’s oral and injectable rare-disease therapeutics across New York’s Hudson Valley. Driving compliant customer engagement, account growth, and territory sales performance.
🗽 New York – Remote
💵 $182k - $210k / year
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales
👻 Ghost score 0%
🕒 August 25
Executive Director leading US payer access and pull-through strategies for BioCryst’s rare-disease therapeutics. Managing market access teams, accounts, launches, and reimbursement partnerships.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 10%
🕒 August 19
Rare Disease Specialist marketing BioCryst’s HAE and rare-disease therapeutics to Detroit-area healthcare customers. Driving compliant sales growth through key-account strategy, field engagement, and customer relationships.
🌲 North Carolina, Michigan – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales
👻 Ghost score 10%
🕒 August 19
Rare Disease Specialist marketing BioCryst’s oral and injectable therapies to healthcare customers in greater Cleveland. Driving compliant demand, key-account growth, and territory sales objectives.
🏈 Ohio – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales
👻 Ghost score 10%
🕒 July 15
Director leading drug product development for BioCryst’s biologics portfolio. Overseeing formulation, process development, and collaboration with external partners.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 11%
🕒 June 23
Leads translational modeling efforts for drug discovery at BioCryst, applying mechanistic PK, PBPK, PK/PD, and QSP approaches.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🟠 Senior
🌎 Translator / Interpreter
👻 Ghost score 16%
🕒 June 11
Director, Quality Control overseeing all QC activities for drug development and manufacturing. Ensuring compliance with global regulations and providing technical leadership in pharmaceutical quality control.
🌲 North Carolina – Remote
💰 $450M Post-IPO Debt - BioCryst Pharmaceuticals on 2023-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 19%